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Abstract
Background: Cellular oxygen sensing is fundamental to all mammalian cells to
adequately respond to a shortage of oxygen by increasing the expression of genes
that will ensure energy homeostasis. The transcription factor Hypoxia-Inducible-
Factor-1 (HIF-1) is the key regulator of the response because it coordinates the
expression of hypoxia inducible genes. The abundance and activity of HIF-1 are
controlled through posttranslational modification by hydroxylases, the cellular oxygen
sensors, of which the activity is oxygen dependent.
Methods: Fluorescence resonance energy transfer (FRET) was established to
determine the assembly of the HIF-1 complex and to study the interaction of the a-
subunit of HIF-1 with the O2-sensing hydroxylase. New software was developed to
improve the quality and reliability of FRET measurements.
Results: FRET revealed close proximity between the HIF-1 subunits in multiple cells.
Data obtained by sensitized FRET in this study were fully compatible with previous
work using acceptor bleaching FRET. Interaction between the O2-sensing hydroxylase
PHD1 and HIF-1a was demonstrated and revealed exclusive localization of O2-
sensing in the nucleus. The new software FRET significantly improved the quality and
speed of FRET measurements.
Conclusion: FRET measurements do not only allow following the assembly of the
HIF-1 complex under hypoxic conditions but can also provide important information
about the process of O2-sensing and its localisation within a cell.
MCS codes: 92C30, 92C05, 92C40
1. Background
Oxygen deprivation of the tissues endangers energy supply and thus function and sur-
vival of the cells. Hypoxia, defined as a state of reduced oxygen tension (PO2), develops
when the demand for oxygen exceeds supply. To restore oxygen and thus energy
homeostasis an adequate response requires the coordinated expression of genes that
control tissue perfusion and oxygen capacity of the blood, glucose uptake and anaero-
bic glycolysis [1]. The key transcriptional regulator of the genomic response to hypoxia
is the transcription factor complex Hypoxia-Inducible Factor-1 (HIF-1) which suppo-
sedly regulates about 5% of the human genome [2]. HIF-1 is formed as a dimer of oxy-
gen-regulated a-subunits (HIF-1a or HIF-2a) and a constitutive nuclear subunit HIF-
1b [3]. Under well oxygenated conditions (normoxia) three enzymes containing prolyl
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original work is properly cited.hydroxylase domains (PHD1, PHD2 and PHD3) posttranslationally modify HIF-a sub-
units. The hydroxylated a-subunits are recognized by the von Hippel-Lindau protein
(pVHL) which recruits an E3 ubiquitin ligase to polyubiquitinate hydroxylated HIF-a
subunits. Subsequently, ubiquitinated HIF-as will be degraded by the 26S proteasomes
[1].
Under hypoxia, HIF-1 can accumulate because PHDs require oxygen and their activ-
ity is greatly reduced under low PO2. Under hypoxic conditions stabilized HIF-as
translocate into the nucleus by not yet defined mechanisms. It is believed that they
immediately dimerize with HIF-1b and recruit the transcriptional co-activators p300/
CBP to the C-terminal activation domain (C-TAD) of HIF-as [3]. This recruitment is
also O2-sensitive because the factor inhibiting HIF-1 (FIH-1), an asparagyl hydroxylase,
impedes binding of co-activators under normoxia due to O2-dependent hydroxylation
of an asparagine residue in HIF-1as [4]. Thus, HIF-1 is controlled both on the level of
abundance and trans-activity of its a-subunits by O2-dependent hydroxylases that act
as cellular oxygen sensors.
Imaging the components of the oxygen sensing mechanisms is difficult. We have
previously localized the nuclear distribution of HIF-1a and of the O2-sensors PHD1,
P H D 2 ,P H D 3a n dF I H - 1[ 5 , 6 ] .S of a r ,i th a sn o tb e e ns u c c e s s f u lt oc r y s t a l l i z ef u l l
length HIF-asa n dH I F - 1 b or even the HIF-1 complex to obtain information of its
structure and potential changes within the complex upon transition from normoxia to
hypoxia and vice versa. Only partial structures of PAS domains B (PAS is an acronym
for Period-Aryl-Hydrocarbon receptor nuclear translocator-Single minded, the foun-
ders of this transcription factor family) which is present in HIF-asa n dH I F - 1 b were
unravelled [7]. It was proposed that within the HIF-1 complex the PAS B domain of
HIF-a and HIF-1b are orientated in an anti-parallel way to form the HIF-1 dimer [7].
This is unusual with respect to other members of the PAS family [8].
Since optical resolution, however, is at best approximately 200 nm, light microscopy
does not allow drawing conclusions with respect to the HIF-1 complex and protein-
protein interaction of its subunits. To analyze the assembly of the HIF-1 complex we
successfully applied fluorescence resonance energy transfer (FRET) [9]. To this aim
HIF-1 subunits were labeled with enhanced cyano (ECFP) or yellow (EYFP) fluorescent
protein [10]. We were able to fit our FRET data with the above mentioned model by
Card et al. to support the notion that N- and C-termini of HIF-1a and HIF-1b make
rather close contact [10].
Nevertheless, the oxygen sensing process itself remains enigmatic. It is still unre-
solved in which cellular compartments HIF-as are degraded at higher oxygen concen-
trations. Very recent attempts to co-localize HIF-1a and PHDs by the use of
fluorescent fusion proteins of HIF-subunits have led to the suggestion that cell-specific
differences exist with respect to the localization of the interaction of HIF-a and the
O2-sensors [11]. In addition to the uncertain subcellular localisation of the interaction,
our understanding how the complex of the O2- s e n s o r s ,i . e .t h eP H D s ,a n dH I F - asi s
formed, is fragmentary. In a very recent study it was suggested that PHD2 forms a
homotrimer with a head-to-tail arrangement of single PHD2 molecules to constitute
the active enzyme complex [12]. This model is based on crystal structure data which
would well explain why PHD2 is isolated as part of a complex much larger than one
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complex is formed in living cells.
Thus, although HIF is recognized as the master regulator of O2-homeostasis, we still lack
detailed knowledge on several key aspects of regulation which is critically needed in view of
the importance of HIF-1 for tumor biology and the pathophysiology of ischemic disease.
To study the assembly of the HIF-1 complex under hypoxic conditions and the inter-
action between PHDs and HIF-1a the microscopic FRET technique was used [13,14].
I nt h el i t e r a t u r eac o u p l eo fm e t h o d sf o rd etection of FRET between fluorophores
attached to interacting protein partners are described [15]. Among them are the tech-
nically challenging fluorescence lifetime analysis of the fluorophores [16], acceptor
bleaching and sensitized FRET techniques [17]. The latter provides the opportunity of
protein-protein interaction analysis without destruction of the acceptor.
Herein, new software is presented that is easy to use for physiologists and biologists
studying intracellular protein-protein-interaction in their specific field of research. To
this aim we want to provide software that should be able to handle most inherent pro-
blems like heterogeneous illumination of the scanned field by the laser when FRET is
performed on the microscope and false positive FRET signals. During scans in each
experiment non-specific energy transfer originating from unspecific dimerization of
fluorophores or random collision should bem e a s u r e db e c a u s en o n - s p e c i f i ce n e r g y
transfer determines the biological and also technical limits of FRET detection in a
given system [18,19]. Areas of overexposure due to precipitation or clumping of fluoro-
phores and areas where no co-localization is found or where fluorescent signals are too
weak for reliable FRET should be excluded from the evaluation. Actual bleed-through
values which may be due to unspecific activation of one fluorophore by the laser speci-
fic for the other partner fluorophore should be automatically and regularly determined.
Finally, the software should display the results of FRET as the sigmoid relation between
the ratio of acceptor to donor fluorescence and FRET efficiency over the whole range
of donor/acceptor ratios. We finally used our new system to determine the proximity
of the two HIF-1 subunits and to prove PHD-HIF-1a interaction in the cell nucleus.
2. Methods
2.1 Cell culture
The human osteosarcoma cells (U-2OS) were grown in Dulbecco’s Modified Eagle’s
Medium (DMEM with 4.5 g/l glucose, L-glutamine, and pyruvate; all from Invitrogen
GmbH, Karlsruhe, Germany) supplemented with penicillin (100 U/ml), streptomycin
(100 μg/ml; Invitrogen GmbH, Karlsruhe, Germany) and 10% fetal bovine serum (FBS;
Biocompare, South San Francisco, USA) in cell culture flask (75 cm
2 bottom area;
Greiner Bio-One GmbH, Solingen, Germany) in a normoxic atmosphere of 21% O2,
74% N2 and 5% CO2 (by vol.) in a Heraeus incubator (Heraeus, Hanau, Germany). For
human embryonal kidney cells (HEK293), DMEM/F-12+GlutaMAX™-I supplemented
with 10% fetal calf serum, 100 U/ml penicillin and 100 μg/ml streptomycin was used.
For FRET experiments cells were grown on glass-bottom cell culture dishes, 3.5 cm in
diameter (WillcoWells BV, Amsterdam, Netherlands) with central glass inserts that
allow all standard formats of microscopy including UV light excitation.
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For transient transfection plasmid DNA was mixed with Fugene6 (Roche, Mannheim,
Germany) and suspended in appropriate volumes of DMEM for each culture dish.
Cells were transfected with the vectors for 24 h, medium was renewed for another 24
h and then again 1 h before starting the experiments. The following plasmids were
used which have been described in detail before [10]: HIF-1a fused to enhanced cyan
fluorescent protein (ECFP; Clontech GmbH, Germany) yielding ECFP-HIF-1a-ECFP-
HIF-1a and HIF-1b fused to enhanced yellow fluorescent protein (EYFP; Clontech
GmbH, Germany) yielding EYFP-HIF-1b, respectively. Prolyl hydroxylase 1 (PHD1)
was fused to EYFP resulting in PHD1-EYFP.
Hypoxic incubations were done in an atmosphere of 1% O2/5% CO2/94% N2 at 37°C
in a chamber specially designed for observation of living cells on microscope stage
under the conditions of controlled temperature, humidity and gas composition, e.g. O2
and CO2 (Luigs & Neumann, Ratingen, Germany) [10]. Gas concentrations were indivi-
dually adjusted by a gas mixing device (Newport Spectra-Physics GmbH, Darmstadt,
Germany) connected to the chamber.
For sensitized FRET analysis of protein-protein-interactions a standard inverted con-
focal microscope with objective lenses plan Apochromat 40× (Nikon GmbH, Düssel-
dorf, Germany) was used with one excitation laser line of 444 nm for ECFP (termed
‘donor’ for FRET measurements) and a second laser between wavelength of 532 nm
for EYFP (termed ‘acceptor’ for FRET) excitation. For FRET two band pass emission
filters 480/40 and 565/40 nm (AHF AG, Tübingen, Germany) were used.
2.3 Correction for shading
Automatic shading correction was implemented using the plugin by Wayne Rasband
(NIH) for ImageJ using the formula for calculating the corrected image B’:B ’ = B*(M/Y)
where B is the image which has to be corrected, M is the mean of the shading image, Y
is the shading image.
2.4 Minimizing errors due to chromatic aberration
In addition, during the scan procedure chromatic aberration was minimized. To this
aim the objective lens was moved 0.5 μm by a piezo stepper during exciting with the
EYFP laser (532 nm) in relation to the excitation with the ECFP laser (444 nm).
2.5 Calibration
To determine the bleed-through and calibrate the systems ECFP fluorescence which is
normally detected in the range of 460-500 nm after excitation with the ECFP laser
(444 nm) was determined in the emission channel for the acceptor EYFP from 545-
585 nm. This was done with cells that only contain the ECFP construct and is called
donor bleed-through (donor BT) when related to the detection of ECFP signal in the
specific EYFP emission channel. Subsequently, the EYFP fluorescence was recorded
after excitation with the ECFP laser in cells that were only transfected with EYFP.
This is called acceptor bleed-through (acceptor BT) when related to the fluorescence
signal in the specific EYFP channel after excitation with EYFP laser. Both measure-
ments are required since during the experiments cells will be co-transfected with both
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method, originally described in [13].
2.6 Data acquisition
To determine protein-protein interaction by FRET cells were transfected with ECFP-
HIF-1a (donor) and EYFP-HIF-1b (acceptor). First, the cells were excited with the
donor laser (444 nm) and the emission was detected in the donor channel (see panel
DD for donor excitation-donor detection in Figure 1). Then emission in the acceptor
channel after donor laser excitation was determined (see panel DA for donor excita-
tion-acceptor detection in Figure 1). Finally, the cells were excited with the EYFP laser
(532 nm) and emission is detected in the acceptor channel (panel AA for acceptor
excitation-acceptor detection in Figure 1). First we calculated Net FRET (nF) according
to [13]:
nF = DA - DD* BTDonor -A A * B T Acceptor, where DA (donor excitation - acceptor
fluorescence), DD (donor excitation - donor fluorescence), and AA (acceptor excitation
- acceptor fluorescence) are intensities in each region of interest (ROI) with FRET,
EYFP, and ECFP filter sets, respectively. BTDonor is the percentage of CFP bleed-
through, and BTAcceptor the percentage of EYFP bleed-through under the FRET filter
set. There were no signals from ECFP with EYFP filter sets and vice versa.
Assuming that the value of non-radiation relaxation processes during/after FRET is
negligible we calculated FRET efficiency for each pixel in the images by the following
formula:
FRET DD DD DA DD BT AA BT eff Donor Acceptor =− + − − 1[ / ( * * ) /] 
According to Vamosi et al. [20] the factor a relates to the ratio of fluorescence quan-
tum yields and the detection efficiencies of both dyes (in our case ECFP and EYFP). In
our analysis we simplified the evaluation by setting a to 1 because results of sensitized
FRET experiments between fluorophore labelled HIF-1a and HIF-1b subunits (Figure 2)
show comparable plateau values as in acceptor bleaching experiments published earlier
[10]. For evaluation, only panels from registration DD and AA with pixel values that are
above and below a respective threshold value were used. As an orientation for
Figure 1 Data acquisition of FRET. Osteosarcoma cells U-2OS were transfected with plasmids expressing
the donor molecule ECFP-HIF-1a and the acceptor EYFP-HIF-1b. 48 h later cells were scanned for
fluorescence and FRET was measured. Data for the panels in the upper row were recorded for panel DD
by donor excitation- donor detection, for panel DA by donor excitation- acceptor detection and in panel
AA by acceptor excitation-acceptor detection.
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determination of BTDonor and BTAcceptor values. The factor a was included according to
Vamosi et al. [20] which relates to the ratio of fluorescence quantum yields of two differ-
ent fluophores (in our case ECFP and EYFP). In our analysis we simplified the evaluation
by setting a to 1. Over a wide range of fluorescence signal the BT values are constant.
Below signal strength of about 10% the photomultiplier dynamic range the BTx values
vary considerably. Above signal strength of 90% of the photomultiplier dynamic range
the BT values show a tendency to exponentially increase with fluorescence intensity of
the fluorophore. Non-transfected cells show very weak auto-fluorescence signals in both
the donor and the FRET channel which are much lower than any fluorescence intensi-
ties from fusion proteins. These low intensities were measured in separate but not con-
sidered in image analysis. Only intensities above these values were included in the
analysis.
For background determination the software will put thirty 15 × 15 pixel squares at
random position over the image. The square with the lowest mean grey value will be
defined as background. The background correction has been implemented into ImageJ.
Overexposed areas, i.e. areas of very high fluorescence signal strength, were not evalu-
ated because of the process of exclusion of fluorescence values from the evaluation
process described above. Due to a sigmoid relationship between the FRET efficiency
and the ratio of acceptor to donor molecules we did not normalized nF. Instead we
show the graphical evaluation the FRET efficiency data.
Figure 2 FRET evaluation of ECF-HIF-1a and EYFP-HIF-1b interaction. Osteosarcoma cells U-2OS were
transfected with plasmids expressing the donor molecule ECFP-HIF-1a and the acceptor EYFP-HIF-1b.4 8h
later cells were scanned for fluorescence and FRET was determined. The black curve indicates random FRET
values as described in detail in Figure 3. Red filled circles show FRET efficiency values from individual cells
which result in mean FRET efficiency for HIF-1a/HIF-1b as indicated by the red curve.
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which is freely available from the National Institutes of Health, USA http://rsbweb.nih.
gov/ij.
3. Results
3.1 Determination of non-specific energy transfer
To obtain reliable FRET results non-specif i ce n e r g yt r a n s f e rv a l u e sh a v et ob et a k e n
into consideration. Cells were only transfected with the vectors for ECFP and EYFP
but not with vectors for fusion proteins with HIF-1 subunits. Cells were transfected
w i t hv e c t o r sc o n t a i n i n ge i t h e rE C F Po rE Y F P alone and fluorescence of ECFP (Figure
3, panel A) and EYFP (Figure 3, panel B) was recorded. Panel C shows non-specific
energy transfer which is particularly prominent at the edge of the cells while low inten-
sity non-specific energy transfer is found over the whole cell area. One way of handling
w i t ht h ef a c to fn o n - s p e c i f i ce n e r g yt r a n s f e ri st os e taF R E Te f f i c i e n c yt h r e s h o l d .
Values below this threshold value are then excluded from the visualization of FRET
efficiency distribution (Panel D). Panel D, however, shows an almost identical picture
as panel C. In panel E and panel F histograms of the frequency distribution of the dif-
ferent non-specific FRET is shown for the pictures from panel C and D respectively.
Only a few very high values cause a mean efficiency of 8% in panel E; interestingly,
cutting off values below a certain threshold (panel F) does not improve the situation
because few high random FRET values shift the mean value to 11.8%. The program
n o wa v o i d st h i sp r o b l e mb yn o ts i m p l yc u t ting-off FRET efficiency values below a
threshold, but weighing their values by frequency for each acceptor/donor ratio. By
these means, less frequent outliers representing unusual high or low values will not be
included in the evaluation. The result is shown in panel H where single FRET efficien-
cies are shown and the sigmoid curve resulting from the mean efficiencies at different
acceptor/donor ratios. The values of this method for determining non-specific energy
transfer were comparable to FRET data where one dimerizing FRET partner was
unable to specifically interact due to a deletion of the interacting domain [21]. Deter-
mination of non-specific energy transfer efficiency was incorporated into the software
and taken into consideration for all FRET measurements (also see Figures 2 and 4).
3.2 Evaluation of ECFP-HIF-1a and EYFP-HIF-1b FRET
The results of the FRET measurements in a single nucleus of an U2OS cell transfected
with ECFP-HIF-1a and EYFP-HIF-1b fusion proteins are shown in the following
panels in Figure 5. Panel A shows the donor emission, in this case, from the ECFP-
HIF-1a fusion protein. Panel B shows the acceptor fluorescence, here EYFP-HIF-1b.
The overlay of both channels results in panel C. From this, in panel D co-localization
areas were calculated which indicate the areas where FRET should be possible. In this
panel, areas with very low signals in the donor or acceptor channel (fluorescence <10%
of the dynamic range of used fluorescence detectors) are shown in blue whereas over-
exposed areas were encoded in red (fluorescence >90% of the dynamic range of used
fluorescence detectors). Both blue and red areas are not included in the evaluation.
This process increases the reliability of FRET determination. Panel E then shows FRET
fluorescence as the result of the radiation less energy transfer from ECFP-HIF-1a to
EYFP-HIF-1b . Panel F contains the calculated FRET efficiency.
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expressing the fluorophores ECFP- and EYFP only. 48 h later cells were scanned for fluorescence and
random FRET was determined. Panel A: ECFP fluorescence after donor excitation; panel B: EYFP acceptor
fluorescence after acceptor excitation; panel C: non-specific energy transfer fluorescence encoded in
pseudo colors and panel E: corresponding frequency distribution of FRET efficiencies; panel D: non-specific
energy transfer fluorescence encoded in pseudo colors after cutting of efficiency values below a certain
threshold and panel F: corresponding frequency distribution of FRET efficiencies; panel H: resulting non-
specific, random FRET curve after weighing FRET efficiencies for their relative frequency.
Wotzlaw et al. PMC Biophysics 2010, 3:5
http://www.physmathcentral.com/1757-5036/3/5
Page 8 of 14Our new software was then used to determine the proximity of the a-a n db-subu-
nits of HIF-1 as shown in Figure 2. FRET was readily detectable in cotransfected
U2OS osteosarcoma cells and allowed to calculate the distance between the two fusion
proteins with about 6.4 nm assuming that the radiation less energy transfer only takes
place between two molecules and without any competition between molecules of the
same form [22]. This result is in good agreement with our previous study using FRET
with the acceptor bleaching method [10].
3.3 Interaction of HIF-1a with PHD1
In addition to understanding the assembly of the HIF-1 complex by FRET, it is impor-
tant to determine the interaction between the oxygen sensors PHDs and HIF-1a subu-
nit. Posttranslational hydroxylation of HIF-1a by PHDs is the key step in oxygen
dependent regulation of the whole HIF-1 complex. Since previous experiments had
shown different compartmentalization of oxygen sensors, i.e. PHD1 localized to the
nucleus and PHD2 and 3 mainly localized to the cytoplasm [5], the localized FRET is
also of considerable interest to understand oxygen sensing. FRET software and FRET
were applied to determine this interaction. To this aim, HEK293 cells were transfected
with ECFP-HIF-1a as the donor molecule and PHD1-EYFP as the acceptor molecule.
Cells were co-transfected and FRET efficiency was determined using FRET software.
Figure 4 FRET evaluation of ECF-HIF-1a and PHD1-EYFP interaction. Embryonic kidney cancer cells
HEK 293 were transfected with plasmids expressing the donor molecule ECFP-HIF-1a and the acceptor
PHD1-EYFP. 48 h later cells were scanned for fluorescence and FRET was determined. The black curve
indicates random FRET efficiency values as described in detail in Figure 3. Filled circles show FRET values
from individual cells which result in mean FRET efficiency for HIF-1a/PHD1 as indicated by the red and
blue curves. Values for the red curve were obtained after treatment of the cells with the PHD1 inhibitor
dimethyloxalylglycine (0.5 mM for 24 h) while the blue curve shows values from untreated controls. The
inserts show donor (ECFP-HIF-1a) and acceptor (PHD1-EYFP) fluorescence and the resulting FRET efficiency
exclusively located in the nuclei of the cells.
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ure. Transfection with the two fusion proteins revealed only moderate FRET efficiency,
as indicated by the blue symbols and the blue sigmoid curve in Figure 4. However,
when dimethyloxalylglycine (DMOG), an inhibitor and pseudo-substrate of PHD1, was
added which causes inhibition of the enzyme and accumulation of HIF-1a,m u c h
higher FRET efficiencies were obtained as shown by the red symbols and the red sig-
moid curve in Figure 4. FRET was exclusively found over the nucleus as shown by the
inserts in Figure 4, clearly demonstrating the advantage of this new software to reliably
determine FRET efficiency with spatial resolution. Furthermore, these data indicate
that oxygen sensing by PHD1 is localized within the nuclear compartment due to the
nuclear interaction of PHD1 with HIF-1a .
4. Discussion
To maintain oxygen homeostasis within cells and the tissue is fundamental for the
human body. Common to the pathophysiology of all ischemic diseases is a lack of oxy-
gen in the cells that causes impaired function or even cell death. Many of these examples
include necrosis of cardiomyocytes after myocardial infarction or necrosis and apoptosis
of neural cells after stroke [23]. In addition, hypoxia plays a fundamental role in tumor
biology. It has been known for many years that hypoxic regions in tumors develop
because tumor cells grow much faster than the oxygen supplying capillaries [24]. In fact,
capillary growth due to an increased oxygen demand has been the hallmark of many
cancers and used for diagnosis, e.g. in malignant glioblastomas. In recent years, it has
Figure 5 Typical recording of a FRET measurement. Osteosarcoma cells U-2OS were transfected with
plasmids expressing the donor molecule ECFP-HIF-1a and the acceptor EYFP-HIF-1b. 48 h later cells were
scanned for fluorescence and FRET was determined. Panel A: ECFP-HIF-1a donor fluorescence after donor
excitation; panel B: EYFP-HIF-1b acceptor fluorescence after acceptor excitation; panel C: overlay of images
in panels A and B; panel D: areas of co-localization (from panel C), very low signal (in blue) or overexposed
areas (in red) and areas with FRET (from panel E); panel E: EYFP-HIF-1b acceptor fluorescence after donor
excitation = FRET fluorescence intensity encoded in grey values as indicated by the bar scale; panel F: FRET
efficiency encoded in grey values as indicated by the bar scale.
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tumor-specific events depend on hypoxia [25]. Apoptosis resistance, metastases and also
genetic instability have now been all attributed to activation of hypoxia-inducible gene
expression under control of hypoxia-inducible factor-1 (HIF-1) [25,26]. While HIF-1
also is in control of angiogenesis and many genes that stimulate and control angiogen-
esis, activation of HIF may also be caused by the tumor phenotype. This can then lead
to induction of glycolytic enzymes despite sufficient oxygen concentration. This phe-
nomenon known as the Warburg effect is another hallmark of malignant cells and an
excellent example how malignant cells make use of physiological adaptation mechanisms
to gain a growth advantage over adjacent host tissue [27].
Not only since HIF-1 has been named “the master regulator of oxygen homeostasis”
[28] attempts have been made to therapeutically intervene with HIF-1 activation. This
may in cases of ischemic diseases be an increased activation of HIF and thus, according
to the control mechanisms, a stabilization of HIF-a subunits [29]. On the other hand,
inhibition of the HIF complex may be required in malignant diseases to decrease the
HIF-1-dependent response of tumor cells. For such fundamental processes at oxygen
sensing and activation of HIF-1, initial studies have to be performed in cell culture sys-
tems in vitro. These systems would provide a well-controlled environment to study
changes in oxygenation with respect to activation of the HIF-1 complex. On the other
hand, even in vitro systems may show heterogeneity of oxygen distribution which com-
plicates experimental setups [30].
So far, molecular biology methods have been applied to study activation of the HIF-1
complex. We have recently introduced fluorescence resonance energy transfer (FRET)
to study the assembly of the HIF complex [10]. Like in the present study, subunits of
HIF-1 were labeled with fluorophores and then transfected into living cells to study
the activation and assembly of the HIF complex. This system relied on the microscopy
of living cells in a well-controlled observation chamber that allowed specification of
oxygen tension, temperature and CO2 for buffering [10]. This system proved to be
very useful since physiological regulation of HIF-1, i. e. accumulation of the a-subunit
under hypoxic conditions, was mostly conserved. Both HIF-1a-a n d- b-subunits bind
to DNA through their basic helix-loop-helix-region in the N-terminal end of the pro-
tein [31]. These parts have also been proposed for dimerisation of the subunit. FRET
analysis revealed a very close assembly when fusion proteins bound to DNA [10].
Recent evidence using deletion constructs in this DNA binding domain revealed that
assembly and close vicinity of the subunits with a distance of only 6.4 nm depends on
D N Ab i n d i n g( R .K o n i e t z n ya n dJ .F a n d r e y ,u n p u b l i s h e d ) .O nt h eo t h e rh a n d ,t h eC -
terminal end of HIF-1a is important for binding additional co-activators and scaffold-
ing proteins that are required for the fully active HIF-1 complex [1,31]. When both C-
terminal ends were labeled with fluorophores, the distance was still close (6.7 nm), but
one may hypothesize that additional factors bound to this end of the protein might
push the two subunits further apart than at the N-terminus where DNA binding
affects proximity of the proteins. Interestingly, an attempt to disrupt FRET by labeling
opposite ends of the protein revealed that FRET was still observed between the end-
terminal DNA bound part of HIF-1 and its the C-terminal part, because FRET calcula-
tions revealed a distance of 7.4 nm [10]. These results were unexpected but obtained
at a time when initial attempts were made to reveal the protein structure by X-ray
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a single subunit or the whole complex has not been achieved yet. Parts of the HIF pro-
tein, the PAS-A and PAS-B domains, where PAS is an acronym delineating the family
of highly related transcription factors Period, ARNT and Single-minded PAS domains
[32]. The group of Gardner et al. was able to crystallize parts of these HIF proteins, in
particular PAS-B structure, and found thatu p o na s s e m b l yo ft h eH I Fc o m p l e xP A S - B
domains will form an antiparallel orientation [7]. Taking this information and combin-
ing it with our in vivo obtained FRET data, makes it likely that the HIF complex is
rather compactly formed in its DNA-bound form which brings the C-terminus of the
HIF complex close to DNA where it could interact through co-activators with other
DNA-binding proteins, for example hepatic nuclear factor-4 (HNF-4), which is
required for tissue-specific expression of the HIF target gene erythropoietin [33]. All in
all, these FRET measurements provided for the first time the required in vivo data of
the HIF complex and were also fully compatible with the only partly revealed X-ray
structure of the PAS domains. One inherent problem of these in vitro studies, how-
ever, is the above-mentioned heterogeneity in oxygen concentration that may also
occur in cell culture. We have therefore set up the present system where multiple cells
can be scanned at the same time to account for these differences in the experimental
setup. Moreover, based on our initial findings, the specificity of FRET of the HIF com-
plex was confined and therefore allowed the use of sensitized FRET. Herein, we show
that several cells can be semi-automatically scanned for fluorescence of the respective
FRET partners which then allows areas of co-localization. The direct determination of
sensitized FRET then provides the examiner with information about the degree of
FRET in the different areas in cells over a whole range of many cells in one individual
experimental setup. This allows for the first time to get an impression about the het-
erogeneity of HIF activation in cells in culture and also in cells growing in close clus-
ters. In addition, the system can be used for dynamic studies since we do no longer
rely on acceptor bleaching which would inevitably destroy one FRET partner. Our sys-
tem is also suitable to study attempts to affect the HIF-1 complex assembly which
appears to become an attractive target to modify activation of the HIF-1 complex [34].
The precise localization of cellular oxygen sensing has been enigmatic. Mostly based
on experiments with cellular extracts, but also immunohistochemical staining studies
have revealed that the cellular oxygen sensors PHD2 and PHD-3 were predominantly
localized to the cytoplasm. In contrast, PHD1 was exclusively detected in the nucleus
[5]. Recent studies in which cells had been modulated in their oxygen sensing capacity
by nitric oxide treatment have shown that the localization of PHD2 can be shifted
from the cytoplasm to the nucleus [35]. Cell fractionation experiments unequivocally
showed that activity of prolyl hydroxylases is found in the nuclear compartment
[35,36].
Our data herein for the first time show that interaction between the oxygen sensor
PHD1 and HIF-1a protein takes place in the nucleus. Interestingly, the interaction was
only detected when the enzymatic activityo fP H D 1w a si n h i b i t e db yt h ep s e u d os u b -
strate inhibitor DMOG (Figure 4). It has been hypothesized that inhibition of the
enzyme may increase the contact time between PHD and the substrate [37]. In our
case, this would indicate that the interaction between PHD1 and HIF-1a is too short-
lived to be detected by FRET without inhibition but last long enough when the enzyme
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Page 12 of 14is inhibited. This hypothesis clearly needs further experimental evidence. With respect
to the localization of FRET, so far mitochondria or the endoplasmatic reticulum have
been considered as a place for cellular oxygen sensor activity. Two very recent studies
indicate that adapter proteins may interact with PHD2 oxygen sensing enzyme to
either determine the stability of PHD2 protein [21] or to affect activity [38]. Interest-
ingly the study by Barth et al. provided evidence obtained by FRET measurements that
an endoplasmatic reticulum bound protein interacts with PHD2 sensors only if cor-
rectly localized and orientated within the cell [21].
It has not been fully resolved yet, how this compartmentalization contributes to oxy-
gen sensing but recent data indicate that nuclear specific activity of prolyl hydroxylases
may be higher than cytoplasmic in many cell types [36]. Our data herein provide a
new tool to study the localized interaction of oxygen sensors and the target protein
HIF-1a in the nucleus. With respect to potential targeting of HIF or the oxygen sen-
sing process itself for therapeutical intervention the nuclear localization has implication
with respect to a strategy: It will be more difficult to target nuclear structures by small
compounds. On the other hand, mechanisms of exclusion or transport into the nucleus
are required for nuclear localization of the oxygen sensors and may thus be a valuable
target.
5. Conclusion
We have set up new FRET software that allows the detection of several cells at the
same time and evaluate FRET efficiency as well as localization of FRET. With respect
to oxygen sensing this will help to clarify the assembly process of the HIF-1 complex
itself but also the mechanisms of compartment-specific cellular oxygen sensing with
particularly focus on nuclear oxygen sensors.
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